Skip to Content
Home
About
Help
Contact
Switch language
English
Switch language
Deutsch
English
Español
Français
Italiano
Português do Brasil
中文
Login
OpenEmory
Emory University
Emory Libraries
Search
Search
Search Constraints
Start Over
Filtering by:
Journal or Parent Publication Title
Am J Nucl Med Mol Imaging
✖
Remove constraint Journal or Parent Publication Title: Am J Nucl Med Mol Imaging
1
-
2
of
2
Sort
by relevance
relevance
date ▼
date ▲
Number of results to display per page
10
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Slideshow
Slideshow
Search Results
Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels.
Authors:
Charles Marcus, Emory University
Olayinka A Abiodun-Ojo, Emory University
Ashesh Jani, Emory University
David Schuster, Emory University
Date:
2021
Publisher:
AJNMMI
Publication Version:
Final Published Version
Exploratory study of 18F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer.
Authors:
Akinyemi A Akintayo, Emory University
Mehmet Bilen, Emory University
Olayinka A Abiodun-Ojo, Emory University
Omer Kucuk, Emory University
Bradley Carthon, Emory University
Zengjia Chen, Emory University
Ashesh Jani, Emory University
Ephraim Parent, Emory University
David Schuster, Emory University
Date:
2021
Publisher:
AJNMMI
Publication Version:
Final Published Version
License:
Creative Commons Attribution-NonCommercial 4.0 International
Limit your search
Authors
Abiodun-Ojo, Olayinka A
2
Jani, Ashesh
2
Schuster, David
2
Akintayo, Akinyemi A
1
Bilen, Mehmet
1
Carthon, Bradley
1
Chen, Zengjia
1
Kucuk, Omer
1
Marcus, Charles
1
Parent, Ephraim
1
Date
2021
2
Journal or Parent Publication Title
Am J Nucl Med Mol Imaging
✖
[remove]
2
Type
Article
2
Publication Version
Final Published Version
2
Keyword
Prostate cancer
2
18F-Fluciclovine
1
18F-fluciclovine
1
PET/CT
1
PSA
1
biochemical recurrence
1
docetaxel
1
metastatic castration-resistant prostate cancer
1
therapy response
1